1.
Dermatology
; 192(3): 283-5, 1996.
Article
in English
| MEDLINE
| ID: mdl-8726651
ABSTRACT
This report describes a patient with metastatic malignant melanoma treated with recombinant human interleukin 4 who developed vitiligo and severe Graves' Disease after therapy. The patient has experienced complete remission of melanoma for 49+ months. The association of antitumor response, vitiligo and thyroid disorders is reviewed.